Plain-English translation of NCT06061120 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is testing whether detailed questionnaires and a special type of heart tracing (called high-resolution ECG) can help doctors better identify which type of irregular heartbeat you have before ablation treatment. Right now, doctors use standard heart tracings that sometimes miss important patterns, especially in conditions like atrial fibrillation. This study hopes to create better tools to pinpoint exactly what kind of arrhythmia you have so your doctor can treat it more effectively.
Many patients with irregular heartbeats have similar symptoms, making it hard for doctors to know exactly which type of arrhythmia they have. By understanding what triggers your heartbeat problems and using more detailed heart tracings, doctors may be able to diagnose and treat these conditions more accurately before ablation.
You likely qualify if…
You likely don't qualify if…
You would complete a detailed questionnaire about what triggers your heart rhythm problems and what stops them, as well as two standard symptom questionnaires. You would also undergo an advanced heart tracing called a high-resolution ECG, which uses extra electrodes placed on your chest to record your heart's electrical activity in much greater detail than a regular ECG. This tracing takes several minutes and is completely non-invasive. Some participants may also have repeat heart tracings after their ablation treatment to see how the procedure affected the patterns doctors observed.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Germany
Sponsor
RWTH Aachen University
Collaborators
Department of Internal Medicine I - Cardiology, KKS -Kardiologisches Klinisches Studienzentrum
Enrollment target
~1,250 participants
Started
September 2021
Primary completion
September 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in September 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Matthias D Zink, MD
RWTH Aachen University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.